Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Cancer Chemother Pharmacol

Retrieve available abstracts of 12 articles:
HTML format
Text format



Single Articles


    June 2017
  1. DEHGHAN-NAYERI N, Eshghi P, Pour KG, Rezaei-Tavirani M, et al
    Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 Jun 5. doi: 10.1007/s00280-017-3347.
    PubMed     Text format     Abstract available


    May 2017
  2. MESRIAN TANHA H, Rahgozar S, Mojtabavi Naeini M
    ABCC4 functional SNP in the 3' splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 May 26. doi: 10.1007/s00280-017-3340.
    PubMed     Text format     Abstract available


    March 2017
  3. GALEOTTI L, Ceccherini F, Domingo D, Laurino M, et al
    Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Mar 13. doi: 10.1007/s00280-017-3271.
    PubMed     Text format     Abstract available


  4. BEN HASSINE I, Gharbi H, Soltani I, Teber M, et al
    hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Mar 12. doi: 10.1007/s00280-017-3266.
    PubMed     Text format     Abstract available


  5. LANVERS-KAMINSKY C
    Asparaginase pharmacology: challenges still to be faced.
    Cancer Chemother Pharmacol. 2017;79:439-450.
    PubMed     Text format     Abstract available


  6. YE YE, Woodward CN, Narasimhan NI
    Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans.
    Cancer Chemother Pharmacol. 2017;79:507-518.
    PubMed     Text format     Abstract available


    October 2016
  7. VARATHARAJAN S, Panetta JC, Abraham A, Karathedath S, et al
    Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  8. FORSTER VJ, van Delft FW, Baird SF, Mair S, et al
    Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


  9. NIELSEN SN, Grell K, Nersting J, Frandsen TL, et al
    Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  10. KIM JH, Lee C, Cheong HS, Koh Y, et al
    SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  11. OGURA M, Ishida T, Tsukasaki K, Takahashi T, et al
    Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  12. DRENBERG CD, Buaboonnam J, Orwick SJ, Hu S, et al
    Evaluation of artemisinins for the treatment of acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: